---
$id: https://graph.org.ai/products/commodity/51201828
$type: Product
source: UNSPSC
code: "51201828"
title: "Levamisole phosphate"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levamisole phosphate

**UNSPSC Code**: 51201828
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a biological response modifier and antihelminthic agent with the molecular formula C11H12N2S.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FIG89N8AZY, chemically known as (s)-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazoletriylium phosphate but more generally known as levamisole phosphate, which bears US NIH Compound Identifier 198119. Most nations, for tariff and trade purposes, schedule levamisole phosphate under HS 29349990. As of Q4 2014, LEVAMISOLE PHOSPHATE remains US FDA's Preferred Term for this commodity. Levamisole phosphate bears US NLM identifiers UMLS ID C0309393 and NCI Concept Code C77331. SMILES: C1CCC(CC1)[C@H]2CN3CCSC3=N2.OP(=O)(O)O.

